Network Connectivity Biomarkers in CBS/PSP

Network Connectivity Biomarkers in Corticobasal Syndrome and Progressive Supranuclear Palsy

Introduction

Network connectivity biomarkers represent a powerful approach for monitoring disease progression in corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). These neuroimaging-derived measures capture the functional and structural disruption that characterizes 4R tauopathies, providing objective metrics that correlate with clinical status and may serve as endpoints in clinical trials.

Network Connectivity Biomarkers in Corticobasal Syndrome and Progressive Supranuclear Palsy

Introduction

Network connectivity biomarkers represent a powerful approach for monitoring disease progression in corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). These neuroimaging-derived measures capture the functional and structural disruption that characterizes 4R tauopathies, providing objective metrics that correlate with clinical status and may serve as endpoints in clinical trials.

Both [corticobasal degeneration](/diseases/corticobasal-degeneration) (CBD) presenting as CBS and [progressive supranuclear palsy](/diseases/progressive-supranuclear-palsy) (PSP) exhibit characteristic patterns of network disruption that reflect the underlying tau pathology and its propagation through anatomically connected pathways. Understanding these patterns enables clinicians and researchers to:

This page synthesizes the evidence for functional connectivity MRI (fcMRI), diffusion tensor imaging (DTI), and related network metrics as biomarkers for CBS and PSP.

Functional Connectivity MRI (fcMRI)

Technical Background

Resting-state functional MRI measures spontaneous low-frequency oscillations (<0.1 Hz) in blood oxygenation level-dependent (BOLD) signal, which reflect synchronized neural activity across spatially distributed brain regions. Functional connectivity analysis examines the temporal correlation between BOLD time series from different brain regions, revealing intrinsic connectivity networks (ICNs) that underlie cognition, motor control, and sensory processing.

Key fcMRI Metrics:

| Metric | Description | Clinical Relevance |
|--------|-------------|---------------------|
| Seed-based correlation | Correlation between a seed region and all other voxels | Network-specific dysfunction |
| Independent component analysis (ICA) | Data-driven decomposition into functional networks | Whole-brain network patterns |
| Graph theory metrics | Global and local network properties (efficiency, clustering) | Topological organization |
| Dynamic connectivity | Time-varying connectivity patterns | Network flexibility |
| Inter-network coupling | Connectivity between major networks | Network interaction |

Acquisition Parameters:

Resting-state fcMRI requires careful acquisition to ensure reliable connectivity estimates:

| Parameter | Recommended | Rationale |
|-----------|-------------|-----------|
| TR | 500-2000ms | Balance temporal resolution vs. SNR |
| Duration | 5-10 minutes | Sufficient temporal degrees of freedom |
| Motion | <3mm/3° run, <0.2mm between runs | Minimize motion artifacts |
| Sampling rate | Higher is better | Capture fast network dynamics |
| Eyes | Eyes closed or fixated | Reduce visual processing variance |

Network Connectivity Patterns in PSP

Default Mode Network Disruption

The default mode network (DMN), comprising the posterior cingulate cortex, precuneus, medial prefrontal cortex, and angular gyrus, shows marked disruption in PSP [@whitwell2015]. This network, critical for self-referential processing and memory consolidation, demonstrates reduced internal connectivity that correlates with executive dysfunction and attentional deficits [@gardner2013].

Key Findings:

• Reduced connectivity between posterior cingulate and medial frontal regions
• Correlation between DMN disruption and PSP Rating Scale (PSPRS) scores
• Parallels cortical hypometabolism patterns on FDG-PET

Salience Network Abnormalities

The salience network, anchored by the anterior insula and dorsal anterior cingulate cortex, plays a critical role in detecting behaviorally relevant stimuli and coordinating network switching [@menon2010]. PSP patients demonstrate both hyperconnectivity and hypoconnectivity within salience network structures, likely reflecting compensatory responses to pathology in connected regions [@whitwell2015a].

Clinical Correlation:

• Altered salience network function may underlie apathy and emotional processing deficits
• Disrupted switching between DMN and central executive networks contributes to cognitive inflexibility

Frontoparietal Control Network

The frontoparietal control network (FPCC), supporting flexible cognitive control and goal-directed behavior, shows consistent disruption in PSP. Meta-analyses have identified reduced frontoparietal connectivity as a robust finding across PSP cohorts, correlating with executive dysfunction and response inhibition deficits.

Network Connectivity Patterns in CBS

Asymmetric Connectivity Changes

The hallmark of CBS on fcMRI is asymmetric network involvement reflecting the characteristic clinical asymmetry [@colgan2016]. This pattern includes:

• Contralateral sensorimotor network disruption corresponding to the more affected body side
• Asymmetric frontoparietal network involvement
• Reduced interhemispheric connectivity in affected networks

| Feature | CBS | PSP |
|---------|-----|-----|
| Laterality | Marked asymmetry | Relative symmetry |
| Sensorimotor involvement | Prominent | Moderate |
| Brainstem connectivity | Variable | Consistently reduced |
| Network specificity | Variable by phenotype | Consistent DMN/FPCC |

Network Disconnection Patterns

CBS demonstrates disconnection patterns that reflect the underlying cortical-subcortical pathology:

PSP vs. CBS Differentiation

Network connectivity metrics can aid in differentiating CBS from PSP, complementing clinical assessment:

| Connectivity Metric | PSP | CBS | Differentiation Value |
|---------------------|-----|-----|----------------------|
| Brainstem-cortical connectivity | Reduced | Variable | High |
| DMN integrity | Markedly reduced | Moderately reduced | Moderate |
| Interhemispheric symmetry | High | Low | High |
| Sensorimotor network | Asymmetric | Asymmetric | Limited |

Diffusion Tensor Imaging (DTI) Metrics

Technical Background

DTI measures water molecule diffusion in brain tissue, providing insights into white matter microstructural integrity. The technique is particularly valuable in CBS/PSP because it can detect abnormalities that precede visible atrophy and quantify the structural connectivity disruption underlying functional connectivity changes.

Core DTI Metrics:

| Metric | Interpretation | Clinical Application |
|--------|----------------|----------------------|
| Fractional anisotropy (FA) | Directionality of diffusion | White matter integrity |
| Mean diffusivity (MD) | Average diffusion rate | Tissue damage |
| Axial diffusivity (AD) | Diffusion along principal axis | Axonal injury |
| Radial diffusivity (RD) | Diffusion perpendicular to axons | Myelin damage |

DTI Findings in PSP

Superior Cerebellar Peduncle

The most consistent DTI finding in PSP is abnormal Superior Cerebellar Peduncle (SCP) integrity [@worker2014]. This tract, connecting the cerebellum to the thalamus and playing a crucial role in motor control and oculomotor function, shows:

• FA: Significantly reduced (<0.45 in PSP vs. >0.55 in controls)
• MD: Elevated in PSP
• RD: Elevated, reflecting demyelination

• Sensitivity: 85%
• Specificity: 88% for differentiating PSP from PD

Brainstem White Matter

DTI reveals extensive brainstem white matter damage extending beyond visible atrophy [@zhang2016]:

• Midbrain: Reduced FA in cerebral peduncles, elevated MD in substantia nigra
• Pons: Variable involvement, generally less affected than midbrain
• Medulla: Distal involvement in advanced disease

Longitudinal Changes

Longitudinal DTI studies demonstrate progressive white matter degeneration [@mak2015]:

| Region | Annual FA Change | Clinical Correlation |
|--------|-------------------|---------------------|
| SCP | -0.02 to -0.04 | Oculomotor impairment |
| Midbrain | -0.01 to -0.03 | Vertical gaze palsy |
| Internal capsule | -0.01 to -0.02 | Motor symptoms |

DTI Findings in CBS

Asymmetric White Matter Abnormalities

The hallmark of CBS on DTI is asymmetric involvement [@bergeron2023]:

• Internal capsule: Markedly reduced FA contralateral to symptoms
• Corona radiata: Elevated MD and RD
• Asymmetry index: >0.10 is characteristic

Regional Patterns

| Region | CBS Finding | Clinical Correlation |
|--------|-------------|----------------------|
| Internal capsule | Asymmetric FA reduction | Apraxia severity |
| Superior longitudinal fasciculus | Reduced FA | Language dysfunction |
| Corpus callosum | Asymmetric involvement | Interhemispheric disconnection |
| Thalamic radiations | Abnormal diffusivity | Sensory integration |

DTI as Progression Biomarker

DTI metrics serve as sensitive biomarkers for disease progression in both CBS and PSP [@quattrone2024]:

Progression Markers:

• Rate of SCP FA decline predicts clinical progression rate
• Midbrain MD elevation correlates with vertical gaze impairment
• Internal capsule asymmetry increase correlates with motor progression

• Baseline SCP FA < 0.40 predicts rapid progression
• Midbrain MD > 0.0012 predicts early falls
• Frontal white matter involvement predicts cognitive decline

Network-Tauopathy Correlation

Network-Based Tau Propagation

The characteristic patterns of network disruption in CBS/PSP reflect the underlying tau pathology propagation along anatomically connected pathways. This "prion-like" spread model proposes that pathological tau species are released from affected neurons, taken up by connected neurons, and template the conversion of normal tau into pathological conformers.

Evidence for Network-Based Propagation:

• Patterns of cortical atrophy correspond to spatial distribution of tau pathology
• Regions with greater connectivity to early-affected sites show earlier pathology
• Tau PET (e.g., ^18F-AV-1451) binding correlates with network connectivity

Hub Vulnerability

Network analysis reveals that specific brain regions—particularly rich club hubs in the basal ganglia, thalamus, and brainstem—show particular vulnerability in CBS/PSP [@crossley2014]. These hub regions:

Clinical-Network Correlation

The relationship between network disruption and clinical phenotype provides insight into disease mechanisms:

| Clinical Feature | Network Disruption | Biomarker Correlation |
|------------------|-------------------|----------------------|
| Oculomotor impairment | Brainstem-cerebellar connectivity | SCP FA |
| Postural instability | Brainstem-spinal connectivity | Midbrain MD |
| Cognitive executive | Frontoparietal connectivity | FPCC metrics |
| Apraxia | Sensorimotor network | Asymmetric internal capsule FA |
| Language impairment | Left frontotemporal connectivity | SLF FA |

Clinical Trial Applications

Biomarker Endpoints

Network connectivity metrics are increasingly used as endpoints in clinical trials for CBS and PSP:

Primary Endpoints:

• SCP FA change (PSP)
• Global network efficiency (CBS)

• Regional connectivity measures
• Network topology changes
• Inter-network coupling

Enrichment Strategies

Baseline network connectivity biomarkers can enrich clinical trials by:

Trial Design Considerations

Multi-site Harmonization:

• ComBat harmonization for scanner differences
• Site-specific normative data
• Standardized acquisition protocols

• Consistent timing between visits
• Motion monitoring and correction
• Longitudinal stability metrics

Integration with Other Biomarkers

Multimodal Assessment

Network connectivity biomarkers provide complementary information when integrated with other biomarker modalities:

| Modality | Information Provided | Integration Value |
|----------|---------------------|-------------------|
| Structural MRI | Atrophy patterns | Structural-functional relationship |
| FDG-PET | Metabolic connectivity | Network dysfunction confirmation |
| Tau PET | Pathology distribution | Pathological basis of connectivity changes |
| CSF biomarkers | Molecular pathology | Pathophysiological context |

Composite Biomarker Panels

Future clinical applications may use composite biomarker panels combining:

• Network connectivity metrics (fcMRI, DTI)
• Molecular biomarkers (CSF tau, neurofilament light)
• Clinical measures (PSPRS, MDS-UPDRS)

Technical Considerations and Limitations

Methodological Considerations

fcMRI Limitations:

• BOLD signal is indirect measure of neural activity
• Physiological noise (cardiac, respiratory) can confound connectivity estimates
• Motion remains significant challenge, especially in neurodegenerative populations

• Crossing fibers cannot be resolved with standard DTI
• Partial volume effects in small structures
• Scanner reproducibility affects longitudinal comparability

Clinical Implementation Barriers

Conclusion

Network connectivity biomarkers—encompassing fcMRI and DTI metrics—provide valuable tools for monitoring disease progression in CBS and PSP. The characteristic patterns of network disruption reflect underlying tau pathology and its propagation through anatomically connected pathways. These biomarkers offer:

• Diagnostic differentiation between CBS, PSP, and other parkinsonisms
• Progression monitoring with quantitative metrics that correlate with clinical status
• Clinical trial endpoints for disease-modifying therapy development
• Personalized medicine through individual network profile characterization

CBS/PSP Cross-Link Hub

This page is part of the CBS/PSP evidence graph and should be interpreted alongside the linked disease, treatment, mechanism, and biomarker pages below.

Related Biomarker Pages

• [DTI White Matter Changes in CBS/PSP](/biomarkers/dti-white-matter-cbs-psp)
• [CSF Biomarkers for CBS/PSP](/biomarkers/csf-biomarkers-cbs-psp)
• [Imaging Biomarkers for CBS/PSP](/biomarkers/imaging-biomarkers-cbs-psp)
• [Plasma Biomarkers for CBS/PSP](/biomarkers/plasma-biomarkers-cbs-psp)
• [Biomarkers for Progressive Supranuclear Palsy](/biomarkers/biomarkers-psp)
• [Tau PET in CBS/PSP](/biomarkers/tau-pet-cbs-psp)

Related Disease Pages

• [Corticobasal Syndrome](/diseases/cbs-clinical-phenotypes)
• [Corticobasal Degeneration](/diseases/corticobasal-degeneration)
• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)

Related Mechanism Pages

• [Brain Network Connectivity in PSP](/mechanisms/brain-network-connectivity-psp)
• [4R Tauopathy Molecular Mechanisms](/mechanisms/4r-tauopathy-molecular-mechanisms)
• [Tau PET in CBS/PSP](/biomarkers/tau-pet-cbs-psp)

References

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [Human Connectome Project](https://www.humanconnectome.org/)
• [FSL Diffusion Toolbox](https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FDT)